Dave Regnery
Analyst · Morgan Stanley. Your line is open.
Josh, this is Dave, I'll take that. And just take a step back, Thermo King business, we have a complete line of products and services that is for the whole coal chain for distribution, whether that's air, truck, trailer, marine, rail, last mile, refrigerated, containers. There are several vaccines I'm sure everyone's aware that are being worked. Some are in Phase 3 trials right now. It's unclear as to which will be first to market. And depending on the vaccine they have different temperature requirements for distribution. So, it ranges from a deep freeze, which could be as cold as minus 80 C to frozen, which rewinds 10 C to just like a pharmaceutical, which would be like 2 C. The markets have sufficient capacity for trailer over the land where we see opportunities is really in three spaces. One is an air, and we've been in the air business for four decades, we have all the approved certifications, whether it's FAA or ESA, which is the equivalent in Europe. We also see some opportunities in last mile. And we see a big opportunity in deep freeze cold storage. And we just have a new product that we introduced there a few months ago, this is a product that in a typical hospital, your deep freeze capability is really about the size of your refrigerator at home. And our solution there is about 60 times the volume that a deep freezer you'd find in a hospital could hold. So, that's going to be a big opportunity for Thermo King. Who we're talking to, we're talking to pharma companies, distribution companies, 3PL, government healthcare providers, we're talking to everyone? And we're going to be ready with the distribution solution storage solution, when that time comes. And hopefully, it's soon when we start distributing vaccines.